8-KFiled Aug 4, 8:00 PM ET
Chipotle Mexican Grill Reports Food-Safety Update After Salmonella Probe
$CMG · CHIPOTLE MEXICAN GRILL INCResearch Summary
AI-generated summary of this SEC filing
Chipotle Mexican Grill Reports Food-Safety Update After Salmonella Probe
What Happened
- Chipotle Mexican Grill (CMG) filed an 8-K on August 5, 2026 disclosing it is cooperating with public health authorities (including the FDA and the Minnesota Department of Health) investigating a salmonella outbreak linked to the supply chain. The Minnesota Department of Health confirmed it has no ongoing concerns with Chipotle.
- After learning of the potential outbreak, Chipotle used its ingredient traceability system and identified jalapeños from a common lot as a potential common ingredient and the restaurants where that lot was distributed. Out of an abundance of caution, the company proactively removed those jalapeños from restaurants and replaced them with product from different growers.
- The company noted its July 29, 2026 earnings release and 2026 outlook reflect information available as of that date and did not include any financial impact from the salmonella investigations due to uncertainty.
Key Details
- Filing date: August 5, 2026 (Form 8-K, Item 7.01 Regulation FD Disclosure).
- Action taken: identified jalapeño lot via traceability system, removed jalapeños from restaurants, and replaced with suppliers from different growers.
- Authorities: cooperating with FDA and Minnesota Department of Health; Minnesota Department of Health reported no ongoing concerns with Chipotle.
- Earnings note: July 29, 2026 earnings release and 2026 outlook did not assume any financial impact from this matter.
Why It Matters
- This is a supply‑chain and food‑safety update that could affect operations or costs if the investigation produces further findings, but the company has not quantified any financial impact.
- For investors, the key takeaways are that Chipotle has taken proactive mitigation steps and that current guidance (July 29, 2026) did not include any impact from this issue—any future material developments could lead to additional disclosures or updates to outlook. Investors should watch for subsequent filings or public-health announcements for further information.